Search Results - "Kakinuma S"

Ikaros is a mutational target for lymphomagenesis in Mlh1-deficient mice.

Authors: Kakinuma, S. Kodama, Y. Amasaki, Y. et al.

Source: Oncogene. 5/3/2007, Vol. 26 Issue 20, p2945-2949. 5p. 1 Chart.

This result is not displayed to guests.
Login for full access.

Human Cord Blood Cells Transplanted Into Chronically Damaged Liver Exhibit Similar Characteristics to Functional Hepatocytes

Authors: Kakinuma, S. Asahina, K. Okamura, K. et al.

Source: Transplantation Proceedings. Jan2007, Vol. 39 Issue 1, p240-243. 4p.

This result is not displayed to guests.
Login for full access.

Genetic susceptibility to thymic lymphomas and K- ras gene mutation in mice after exposure to X-rays and N -ethyl- N -nitrosourea.

Authors: Shimada, Y. Nishimura, M. Kakinuma, S. et al.

Source: International Journal of Radiation Biology. Jun2003, Vol. 79 Issue 6, p423. 8p.

Characteristic association between K-ras gene mutation with loss of heterozygosity in X-ray-induced thymic lymphomas of the B6C3F1 mouse.

Authors: Shimada, Y. Nishimura, M. Kakinuma, S. et al.

Source: International Journal of Radiation Biology. Apr2001, Vol. 77 Issue 4, p465-473. 9p. 3 Charts, 3 Graphs.

Individualising radiation cancer risk: insights from animal studies.

Authors: Imaoka, T. Nagata, K. Nakamura, Y. et al.

Source: Annals of the ICRP. May2026, p1.

Individual response of humans to ionising radiation: governing factors and importance for radiological protection.

Authors: Applegate, K. E. Rühm, W. Wojcik, A. et al.

Source: Radiation & Environmental Biophysics. May2020, Vol. 59 Issue 2, p185-209. 25p.

Aloe vera oral administration accelerates acute radiation-delayed wound healing by stimulating transforming growth factor-[beta] and fibroblast growth factor production.

Authors: Atiba A Nishimura M Kakinuma S et al.

Source: American Journal of Surgery. Jun2011, Vol. 201 Issue 6, p809-818. 10p.

Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.

Authors: Itsui, Y. Sakamoto, N. Kurosaki, M. et al.

Source: Journal of Viral Hepatitis. Oct2006, Vol. 13 Issue 10, p690-700. 11p.

Site-specific mutation of the interferon sensitivity-determining region (ISDR) modulates hepatitis C virus replication.

Authors: Kohashi, T. Maekawa, S. Sakamoto, N. et al.

Source: Journal of Viral Hepatitis. Sep2006, Vol. 13 Issue 9, p582-590. 9p. 5 Graphs.

Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study.

Authors: Ohwada, S Ikeya, T Yokomori, T et al.

Source: British Journal of Cancer. 3/8/2004, Vol. 90 Issue 5, p1003-1010. 8p.

The Immunomodulatory Effects of Carbon-Ion Therapy on Solid Tumors.

Authors: Spina, C.S. Tsuruoka, C. Mao, W. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2019 Supplement, Vol. 105, pS124-S124. 1p.

P0332 : Gene alterations in tert promoter, CTNNB1, and TP53 are closely associated with development and prognosis of hepatocellular carcinoma: Comprehensive analyses by next generation sequencing technology.

Authors: Asahina, Y. Kawai-Kitahata, F. Kaneko, S. et al.

Source: Journal of Hepatology. Apr2015 Supplement 2, Vol. 62, pS434-S434. 1p.

681: Mutations and expression of genes in PI3K-AKT pathwayin radiation-induced mammary carcinoma of (Sprague-Dawley × Copenhagen) F1 hybrid rats.

Authors: Nishimura, M. Showler, K. Daino, K. et al.

Source: European Journal of Cancer. Jul2014 Supplement 5, Vol. 50, pS163-S164. 1p.

578: Critical age windows of radiation exposure for cancer risk in experimental animal models.

Authors: Shimada, Y. Nishimura, M. Imaoka, T. et al.

Source: European Journal of Cancer. Jul2014 Supplement 5, Vol. 50, pS139-S139. 1p.

P1115 IMPAIRED IL28B GENE INDUCTION AND EXPRESSION OF IFN-LAMBDA4 ARE CLOSELY ASSOCIATED WITH A NON-RESPONSE TO INTERFERON-BASED THERAPY IN CHRONIC HEPATITIS C PATIENTS.

Authors: Asahina, Y. Murakawa, M. Kawai, F. et al.

Source: Journal of Hepatology. Apr2014 Supplement, Vol. 60, pS450-S450. 1p.

789 SERUM INTERLEUKIN-6 LEVELS DURING TREATMENT CORRELATE WITH RESISTANCE TO TELAPREVIR-BASED TRIPLE THERAPY IN CHRONIC HEPATITIS C.

Authors: Asahina, Y. Nakagawa, M. Taniguchi, M. et al.

Source: Journal of Hepatology. Apr2013 Supplement 1, Vol. 58, pS321-S321. 1p.

469 ITPA GENE VARIANT PROTECTS AGAINST TREATMENT-INDUCED ANEMIA AND IMPROVES VIRAL CLEARANCE BY PEGYLATED INTERFERON-ALFA AND RIBAVIRIN THERAPY IN CHRONIC HEPATITIS C PATIENTS

Authors: Sakamoto, N. Tanaka, Y. Nakagawa, M. et al.

Source: Journal of Hepatology. Mar2011 Supplement 1, Vol. 54, pS191-S192. 0p.

661 COMPARISON OF HCV-ASSOCIATED GENE EXPRESSION AND CELL SIGNALING PATHWAYS IN CELLS WITH OR WITHOUT HCV REPLICON AND IN REPLICON-CURED CELLS

Authors: Nishimura-Sakurai, Y. Sakamoto, N. Mogushi, K. et al.

Source: Journal of Hepatology. Apr2010 Supplement 1, Vol. 52, pS258-S258. 1p.